BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33686968)

  • 1. A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
    Wang K; Guan C; Shang X; Ying X; Mei S; Zhu H; Xia L; Chai Z
    Aging (Albany NY); 2021 Mar; 13(5):7416-7429. PubMed ID: 33686968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [IgG Fc binding protein (FCGBP) as a prognostic marker of low-grade glioma and its correlation analysis with immune infiltration].
    Liu Q; Zhang J; Zhang F; Zhang W; Gong L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Aug; 39(8):686-692. PubMed ID: 37515334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment.
    Ding Q; Lin F; Huang Z; Li Y; Cai S; Chen X; Liu H; Qiu S
    Sci Rep; 2024 Feb; 14(1):4426. PubMed ID: 38396056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc fragment of IgG binding protein is correlated with immune infiltration levels in hepatocellular carcinoma.
    Suo Y; Hou C; Yang G; Yuan H; Zhao L; Wang Y; Zhang N; Zhang X; Lu W
    Biomol Biomed; 2023 Jul; 23(4):605-615. PubMed ID: 36803544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.
    Shen T; Zhang J; Wang Y; Liu B
    J Immunol Res; 2022; 2022():8443392. PubMed ID: 35733916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG Fc Binding Protein (
    Yuan Z; Zhao Z; Hu H; Zhu Y; Zhang W; Tang Q; Huang R; Gao F; Zou C; Wang G; Wang X
    Onco Targets Ther; 2021; 14():967-977. PubMed ID: 33603401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma.
    Yan T; Tian D; Chen J; Tan Y; Cheng Y; Ye L; Deng G; Liu B; Yuan F; Zhang S; Cai L; Chen Q
    Front Oncol; 2021; 11():769033. PubMed ID: 35047393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
    Liu J; Tan Z; He J; Jin T; Han Y; Hu L; Song J; Huang S
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33043974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and immunological roles of Fc fragment of IgG binding protein in colorectal cancer.
    Zhuang Q; Shen A; Liu L; Wu M; Shen Z; Liu H; Cheng Y; Lin X; Wu X; Lin W; Li J; Han Y; Chen X; Chen Q; Peng J
    Oncol Lett; 2021 Jul; 22(1):526. PubMed ID: 34055091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma.
    Lin YH; Yang YF; Shiue YL
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implication and immunological characterisation of the ARF-GEF family member CYTH4 in ovarian cancer.
    Zhang Q; Wang Q; Wu S; Zhang J
    Autoimmunity; 2020 Dec; 53(8):434-442. PubMed ID: 33078956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer.
    Liu C; Zhou X; Zeng H; Wu D; Liu L
    Front Oncol; 2021; 11():597860. PubMed ID: 33816230
    [No Abstract]   [Full Text] [Related]  

  • 13. Different Forms of TFF3 in the Human Endocervix, including a Complex with IgG Fc Binding Protein (FCGBP), and Further Aspects of the Cervico-Vaginal Innate Immune Barrier.
    Laskou A; Znalesniak EB; Harder S; Schlüter H; Jechorek D; Langer K; Strecker C; Matthes C; Tchaikovski SN; Hoffmann W
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396964
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhao K; Yi Y; Ma Z; Zhang W
    Front Genet; 2021; 12():705512. PubMed ID: 35058963
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the mucin-like glycoprotein FCGBP in mucosal immunity and cancer.
    Liu Q; Niu X; Li Y; Zhang JR; Zhu SJ; Yang QY; Zhang W; Gong L
    Front Immunol; 2022; 13():863317. PubMed ID: 35936008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.
    Wang H; Li G; Yin Y; Wang J; Wang H; Wei W; Guo Q; Ma H; Shi Q; Zhou X; Wang J
    Int J Clin Exp Pathol; 2014; 7(11):7881-9. PubMed ID: 25550828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
    Hachim MY; Hachim IY; Talaat IM; Yakout NM; Hamoudi R
    Front Immunol; 2020; 11():560074. PubMed ID: 33304345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
    Hinchcliff E; Paquette C; Roszik J; Kelting S; Stoler MH; Mok SC; Yeung TL; Zhang Q; Yates M; Peng W; Hwu P; Jazaeri A
    Cancer Immunol Immunother; 2019 Sep; 68(9):1515-1526. PubMed ID: 31515669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of KIF26B, Cell Migration and Proliferation of Human Ovarian Cancer Cell Lines In Vitro, and Patient Outcomes from Human Bioinformatic Analysis.
    Yang X; Zhang L; Xie L
    Med Sci Monit; 2018 Jun; 24():3863-3872. PubMed ID: 29880787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Prognostic Marker and Therapeutic Target Associated with Glioma Progression in a Tumor Immune Microenvironment.
    Zhang JJ; Zhang Y; Chen Q; Chen QN; Yang X; Zhu XL; Hao CY; Duan HB
    J Inflamm Res; 2023; 16():895-916. PubMed ID: 36883185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.